Company intelligence / Profile preview

Kiro Robotics

Mondragon, Gipuzkoa, Spain

Ownership: Private
Development stage: Other

Overview

Kiro Grifols specializes in the automation of sterile IV drug compounding for hospital pharmacies, particularly for hazardous and non-hazardous preparations. Its robotic platforms (e.g., Kiro Oncology) are adopted by major hospitals in the US, EU, and Asia for precision, safety, and efficiency in preparing individualized oncology and sterile medications, including chemotherapy[1][2][7]. The company has received international recognition for innovation in hospital pharmacy robotics, including the iF Design Award[3][6].

Modalities: DeviceRobotic automationSoftware
Industry: Therapeutic Medical Devices

Partnerships

Mondragon Corporation (spin-off origin, prior to acquisition)Major US and European oncology hospitals (for technology adoption)

Beyond the preview

Go deeper on Kiro Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kiro Robotics.

Explore the full profile